Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse.
about
Efficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization.Effect of natural exogenous antioxidants on aging and on neurodegenerative diseasesRole of early life exposure and environment on neurodegeneration: implications on brain disordersReview: taurine: a "very essential" amino acid.Ketogenic diets: from cancer to mitochondrial diseases and beyond.Ginkgo biloba extract in an animal model of Parkinson's disease: a systematic review.Acute morphine treatments alleviate tremor in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.Ginsenoside Rd Protects SH-SY5Y Cells against 1-Methyl-4-phenylpyridinium Induced Injury.Mitochondrial Complex 1 Activity Measured by Spectrophotometry Is Reduced across All Brain Regions in Ageing and More Specifically in Neurodegeneration.L-DOPA in the hu man ovarian follicular fluid acts as an antioxidant factor on granulosa cells.Enhanced Neuroprotective Effects of Coadministration of Tetrandrine with Glutathione in Preclinical Model of Parkinson's Disease.Bioassay-guided isolation, identification of compounds from Origanum rotundifolium and investigation of their antiproliferative and antioxidant activities.Mitochondrial injury and cognitive function in HIV infection and methamphetamine use.Cocaine induces astrocytosis through ER stress-mediated activation of autophagyAssociation between GSTM1 and GSTT1 polymorphisms and susceptibility to methamphetamine dependence.Neuroprotective effects of a variety of pomegranate juice extracts against MPTP-induced cytotoxicity and oxidative stress in human primary neurons.Heptachlor induced nigral dopaminergic neuronal loss and Parkinsonism-like movement deficits in mice.A mitochondrial location for haemoglobins--dynamic distribution in ageing and Parkinson's diseaseOxidative stress in aging--matters of the heart and mind.Paraoxonase 1 in neurological disorders.An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease.Early Alzheimer's and Parkinson's disease pathology in urban children: Friend versus Foe responses--it is time to face the evidence.Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical ApplicationsMitochondrial dynamics in Parkinson's disease: a role for α-synuclein?Serum lipid levels are associated with the prevalence but not with the disease progression of multiple system atrophy in a Chinese population.Dopamine in human follicular fluid is associated with cellular uptake and metabolism-dependent generation of reactive oxygen species in granulosa cells: implications for physiology and pathology.Expanded and Wild-type Ataxin-3 Modify the Redox Status of SH-SY5Y Cells Overexpressing α-Synuclein.Interaction of curcumin with manganese may compromise metal and neurotransmitter homeostasis in the hippocampus of young mice.Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.Zinc and linoleic acid pre-treatment attenuates biochemical and histological changes in the midbrain of rats with rotenone-induced Parkinsonism.MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortexRecent Advances in Biomarkers for Parkinson's Disease
P2860
Q27304699-670B4180-D79E-4AF2-895E-B157B74184C9Q28289119-C0A55988-A0A7-47B3-AD31-CFDBF6B30DC5Q28386323-DD8A8C46-CC69-45D2-B5F0-DF3BB93F2DF8Q34312980-A4095126-C6A2-4351-9036-025C4CDA1C68Q34509699-4117B5AA-8D4C-499F-8E19-BC2333FEF30FQ35079320-6272CEC7-761C-49E7-AA70-6E6D4DFFFDD0Q35092815-C2B83396-0374-41FC-8BE2-AFD128D6458BQ35889862-4459A3C5-037D-4C47-9673-9293BB61A446Q35902386-437E54F7-0FA6-4D5A-8663-A4E920A7EA5AQ36059079-8E1C7EE0-9670-4E6D-9146-21AE8CD8BF37Q36149073-D3801EFB-B5BE-4344-9941-010177DE6845Q36339666-D94274FA-FAA5-4145-8058-AEB24056B064Q36353775-CF7663C9-3DA7-4F0F-98C8-50EF366590DFQ36669762-52630879-165F-4CE8-917D-BF0465A4272DQ37141770-36C84E71-D920-40F4-939C-B22029A2C120Q37248734-CE092714-60B6-4146-8201-C23268422CE9Q37275312-F4D01B26-4E23-43A2-A779-A20BA2536C0AQ37621012-F46EAF58-39CA-41A3-AEF9-F75F6C665361Q37671549-5BE67E0A-A8F9-47E4-A934-723C83F619C4Q38133938-649ADE86-0C34-4BC7-A70A-860964852026Q38162323-5DDC001F-F090-4796-9D7D-9D8BA73D4C08Q39012982-318928B1-2423-4781-AB63-0A80B55393DDQ40099231-17EAAA79-4DB8-4E30-B96A-09029693DD6FQ41141816-A6091FD8-0338-4EF7-A45F-1C860C109111Q41664833-7A3B48BE-80C1-4228-AA9B-E8DA5A88C3CDQ44466026-84F84A7E-7472-4812-9802-8AAFFA1BDAB4Q46965942-43666F96-D696-4664-BBFB-C7C0AA7D22FBQ48195020-225B37A7-627E-48F3-A259-DE33CDD826DFQ50671154-30551CCF-6640-49F4-B5A0-A8BE28CC31C1Q52332617-C0E18EC1-B8A8-4071-A9E6-672FF8E5E31AQ55131753-16C59340-EE6A-4A37-AF8F-5767CECABEE5Q57778958-0A88514F-D444-43C5-AE3D-D278F8918782Q58572579-139CDD01-9260-4060-98D4-5B13EFAA41A3
P2860
Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Revisiting oxidative stress an ...... of amphetamine drugs of abuse.
@en
type
label
Revisiting oxidative stress an ...... of amphetamine drugs of abuse.
@en
prefLabel
Revisiting oxidative stress an ...... of amphetamine drugs of abuse.
@en
P2093
P50
P1476
Revisiting oxidative stress an ...... of amphetamine drugs of abuse
@en
P2093
Ana Cristina Rego
Rita Perfeito
Teresa Cunha-Oliveira
P304
P356
10.1016/J.FREERADBIOMED.2012.08.569
P577
2012-08-25T00:00:00Z